...
首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia
【24h】

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

机译:罗马纳3:高级非小细胞肺癌(NSCLC)患者的Anamorin患者第3期安全延伸研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Cancer anorexia-cachexia is a debilitating condition frequently observed in NSCLC patients, characterized by decreased body weight, reduced food intake, and impaired quality of life. Anamorelin, a novel selective ghrelin receptor agonist, has anabolic and appetite-enhancing activities.
机译:背景:癌症厌食症 - 恶病症是在NSCLC患者中经常观察到的衰弱条件,其体重减少,食物摄入量减少,生活质量受损。 一种新颖的选择性Ghrelin受体激动剂,Anamorelin具有合成代谢和食欲增强的活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号